BackSeneca Biopharma Overview

Seneca Biopharma Operating Income

Operating Income for SNCA.

Quarterly Operating Income

$-10675546.00
400.59% YoY

As of Dec 31, 2020

Annual Operating Income (TTM)

$-14934637.00
70.79% YoY

Trailing 12 months ending Dec 31, 2020

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)